JTC Employer Solutions Trustee Ltd Sells 695 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

JTC Employer Solutions Trustee Ltd cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 23.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,214 shares of the financial services provider’s stock after selling 695 shares during the period. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $322,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Global Assets Advisory LLC purchased a new position in iShares Biotechnology ETF during the 1st quarter worth $66,059,000. BNP Paribas Financial Markets grew its stake in iShares Biotechnology ETF by 25.7% during the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock worth $282,038,000 after buying an additional 420,053 shares during the last quarter. Jane Street Group LLC purchased a new position in iShares Biotechnology ETF during the 1st quarter worth $14,386,000. Cetera Investment Advisers grew its stake in iShares Biotechnology ETF by 689.4% during the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after buying an additional 79,541 shares during the last quarter. Finally, State of Michigan Retirement System grew its stake in iShares Biotechnology ETF by 150.0% during the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after buying an additional 75,000 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $145.91 on Friday. The stock’s fifty day moving average price is $145.65 and its 200 day moving average price is $139.65. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.